恒指创2022年以来新高！主力猛攻这两大赛道

Group 1 - The Hang Seng Index reached a new high of 25120.68 points, marking the highest level since 2022, with a year-to-date increase of 25% [1][2][4] - Despite recent fluctuations, the Hong Kong stock market is considered undervalued, with significant net inflows from mainland investors and increased holdings by state-owned enterprises [1][4][6] - The market sentiment is improving, and analysts remain optimistic about the future performance of the Hong Kong stock market [1][6][7] Group 2 - The active inflow of southbound funds has been notable, with net purchases reaching 971.36 billion yuan in the past month and a total of 0.79 trillion yuan year-to-date [4] - Public funds have shown increased interest in Hong Kong stocks, with the total scale of actively managed funds reaching 325.9 billion yuan, up from 19.13% to 19.92% of total heavy holdings [4][6] - The performance of new consumption and innovative pharmaceutical sectors has significantly boosted market sentiment, with stocks like Pop Mart seeing a price increase of over 250% this year [8][9] Group 3 - The innovative pharmaceutical sector has outperformed, with related ETFs showing year-to-date gains exceeding 80%, indicating strong investor interest [9][10] - The biotechnology and medical technology sectors in Hong Kong account for 40% of the total market capitalization in the pharmaceutical sector, compared to 24% in A-shares, suggesting a higher level of innovation in Hong Kong stocks [10][11]